Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -885 | -478 | -242 | -979 | -717 |
| Accounts receivable | N/A | N/A | N/A | 7,000 | N/A |
| Other Working Capital | 1,050 | 941 | -60 | 7,884 | 6,886 |
| Other Operating Activity | 0 | 0 | 0 | -7,000 | 0 |
| Operating Cash Flow | $165 | $463 | $-302 | $6,905 | $6,169 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -300 | N/A | N/A | N/A | N/A |
| Dividend Paid | N/A | N/A | N/A | -7,959 | -2,653 |
| Financing Cash Flow | $-300 | $N/A | $N/A | $-7,959 | $-2,653 |
| Beginning Cash Position | 5,446 | 5,446 | 5,446 | 6,500 | 6,500 |
| End Cash Position | 5,311 | 5,909 | 5,144 | 5,446 | 10,016 |
| Net Cash Flow | $-135 | $463 | $-302 | $-1,054 | $3,516 |
| Free Cash Flow | |||||
| Operating Cash Flow | 165 | 463 | -302 | 6,905 | 6,169 |
| Free Cash Flow | 165 | 463 | -302 | 6,905 | 6,169 |